We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKNG icon
276
Booking.com
BKNG
$150B
$7.44M 0.07%
108,775
-33,825
-24% -$2.38M
ASMB icon
277
Assembly Biosciences
ASMB
$516M
$7.4M 0.07%
+37,500
New +$9.44M
EXPD icon
278
Expeditors International
EXPD
$21.8B
$7.35M 0.07%
81,187
+69,411
+589% +$5.91M
AMRC icon
279
Ameresco
AMRC
$1.09B
$7.24M 0.07%
+216,904
New +$6.57M
VFC icon
280
VF Corp
VFC
$5.87B
$7.23M 0.07%
102,871
+4,064
+4% +$263K
BNY
281
Bank of New York Mellon
BNY
$106B
$7.22M 0.07%
210,407
+35,921
+21% +$1.31M
STT icon
282
State Street
STT
$50.2B
$7.18M 0.07%
121,014
-2,959
-2% -$192K
AXSM icon
283
Axsome Therapeutics
AXSM
$12.1B
$7.16M 0.07%
+100,455
New +$7.83M
HPQ icon
284
HP
HPQ
$24.6B
$7.13M 0.07%
375,748
-36,160
-9% -$660K
URI icon
285
United Rentals
URI
$66.5B
$7.08M 0.07%
40,584
+6,986
+21% +$1.17M
VIR icon
286
Vir Biotechnology
VIR
$1.5B
$7.06M 0.07%
+205,622
New +$8.85M
WST icon
287
West Pharmaceutical
WST
$23.9B
$7.05M 0.07%
25,657
-5,439
-17% -$1.44M
BE icon
288
Bloom Energy
BE
$61B
$7.02M 0.07%
+390,615
New +$5.83M
YMAB
289
DELISTED
Y-mAbs Therapeutics
YMAB
$7.01M 0.07%
182,704
+17,707
+11% +$705K
EW icon
290
Edwards Lifesciences
EW
$50B
$6.96M 0.07%
87,263
-6,574
-7% -$513K
AERI
291
DELISTED
Aerie Pharmaceuticals
AERI
$6.96M 0.07%
591,800
– –
FRC
292
DELISTED
First Republic Bank
FRC
$6.9M 0.06%
63,300
+1,407
+2% +$156K
PGR icon
293
Progressive
PGR
$124B
$6.87M 0.06%
72,529
+2,055
+3% +$185K
MYOV
294
DELISTED
Myovant Sciences Ltd.
MYOV
$6.84M 0.06%
486,864
+265,461
+120% +$4.94M
QIWI
295
DELISTED
QIWI PLC
QIWI
$6.83M 0.06%
393,800
+10,000
+3% +$180K
LUV icon
296
Southwest Airlines
LUV
$22.3B
$6.82M 0.06%
181,978
-461
-0.3% -$16.4K
F icon
297
Ford
F
$59.3B
$6.79M 0.06%
1,020,108
+751,079
+279% +$5.09M
FFIV icon
298
F5
FFIV
$22.1B
$6.76M 0.06%
55,104
+34,647
+169% +$4.66M
ODFL icon
299
Old Dominion Freight Line
ODFL
$44.2B
$6.76M 0.06%
74,778
-8,780
-11% -$824K
WMB icon
300
Williams Companies
WMB
$86.7B
$6.75M 0.06%
343,663
-13,575
-4% -$276K
10 11
12
13 14

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.